CVS Health (CVS) Q4 2025 Earnings
A pedestrian walks past a CVS store in Greenbrae, California, on July 31, 2025. Justin Sullivan | fake images CVS…
Pharmaceuticals
Novo Nordisk sues Hims & Hers over compounded obesity drugs
Nordisk on Monday said he is suing an online telehealth provider him and her to mass market cheaper, unapproved copies…
Merck (MRK) earnings in Q4 2025
Merck on Tuesday reported fourth-quarter earnings and revenue that beat estimates due to strong demand for its Keytruda cancer immunotherapy…
Hims & Hers pulls knockoff weight-loss pill after legal threats
Piotr Swat | Light rocket | fake images him and her on Saturday said it will pull its knock-off weight-loss…
Eli Lilly CEO David Ricks Discusses Medicare Coverage of Obesity Pills
Eli Lilly Chief Executive Dave Ricks said Friday that upcoming Medicare coverage of obesity drugs could be a major catalyst…
Eli Lilly plans $3.5 billion plant in Pennsylvania for obesity drugs
Eli Lilly Chairman and CEO Dave Ricks speaks during a news conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
UnitedHealth Group (UNH) Earnings in Q4 2025
UnitedHealth Group Inc. signs on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Wednesday,…
Another Alliance Between Healthcare and AI Indicates Why Pharma Stocks Could Make a Comeback
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…
Novo Nordisk and Pfizer executives weigh in
US President Donald Trump arrives to make an announcement in the Roosevelt Room of the White House in Washington, DC,…
Novo Nordisk shares rise after launch of anti-obesity pill Wegovy
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, on January 15, 2026. George Frey…